David H. Miller

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

Medicine, Neurology, Pharmacology +6

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

Leonora Fisniku, P A Brex, Daniel R. Altmann et al. · Brain · 2008 · 894 citations · Full text

Medicine, Neurology, Neuroscience +15

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

Peter Brex, Olga Ciccarelli, J O’Riordan et al. · New England Journal of Medicine · 2002 · 863 citations · Full text

Medicine, Neurology, Radiology +10